Insider Transactions in Q3 2025 at Lexaria Bioscience Corp. (LEXX)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 30
2025
|
Christopher Bunka Director |
BUY
Open market or private purchase
|
Indirect |
11,900
+4.05%
|
$0
$0.91 P/Share
|
|
Jul 29
2025
|
Christopher Bunka Director |
BUY
Open market or private purchase
|
Indirect |
15,600
+5.46%
|
$0
$0.92 P/Share
|
|
Jul 29
2025
|
William Edward Mc Kechnie Director |
BUY
Open market or private purchase
|
Direct |
5,000
+21.56%
|
$0
$0.91 P/Share
|
|
Jul 29
2025
|
John Martin Docherty President & CSO |
BUY
Open market or private purchase
|
Direct |
5,376
+50.0%
|
$0
$0.93 P/Share
|
|
Jul 29
2025
|
Vanessa Carle Secretary |
BUY
Open market or private purchase
|
Direct |
750
+50.0%
|
$0
$0.91 P/Share
|
|
Jul 29
2025
|
Richard Christopher Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
15,000
+18.75%
|
$0
$0.91 P/Share
|